Real-world experience of 45 patients using intranasal esketamine for treatment-resistant depression

Neuroscience Applied 2026 Open access

Read full text

Authors: C. De Oliveira Lapa, J.R. Garcia e Silva, S.C. Coral, L. Spanemberg

DOI: 10.1016/j.nsa.2025.105745

Cited by: 0

Fields of Study & Subjects

Treatment of Major Depression Neurotransmitter Receptor Influence on Behavior Psychedelics and Drug Studies